Beating the odds: efficacy and toxicity of dihydropyrimidine dehydrogenase-driven adaptive dosing of 5-FU in patients with digestive cancer
出版年份 2015 全文链接
标题
Beating the odds: efficacy and toxicity of dihydropyrimidine dehydrogenase-driven adaptive dosing of 5-FU in patients with digestive cancer
作者
关键词
-
出版物
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 81, Issue 1, Pages 124-130
出版商
Wiley
发表日期
2015-09-22
DOI
10.1111/bcp.12790
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Genotyping of a family with a novel deleteriousDPYDmutation supports the pretherapeutic screening of DPD deficiency with dihydrouracil/uracil ratio
- (2015) F Thomas et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Undetected Toxicity Risk in Pharmacogenetic Testing for Dihydropyrimidine Dehydrogenase
- (2015) Felicia Falvella et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Discovery of novel mutations in the dihydropyrimidine dehydrogenase gene associated with toxicity of fluoropyrimidines and viewpoint on preemptive pharmacogenetic screening in patients
- (2015) Marzia Del Re et al. EPMA Journal
- Pretherapeutic uracil and dihydrouracil levels in saliva of colorectal cancer patients are associated with toxicity during adjuvant 5-fluorouracil-based chemotherapy
- (2014) Göran Carlsson et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-Analysis
- (2014) Dan Rosmarin et al. JOURNAL OF CLINICAL ONCOLOGY
- Predicting 5-fluorouracil toxicity: DPD genotype and 5,6-dihydrouracil:uracil ratio
- (2014) Johanna Sistonen et al. PHARMACOGENOMICS
- Influence ofDPYDGenetic Polymorphisms on 5-Fluorouracil Toxicities in Patients with Colorectal Cancer: A Meta-Analysis
- (2014) Qiang Li et al. Gastroenterology Research and Practice
- DPYDIVS14+1G>A and 2846A>T genotyping for the prediction of severe fluoropyrimidine-related toxicity: a meta-analysis
- (2013) Salvatore Terrazzino et al. PHARMACOGENOMICS
- Evaluation of predictive tests for screening for dihydropyrimidine dehydrogenase deficiency
- (2013) M C van Staveren et al. PHARMACOGENOMICS JOURNAL
- Evaluation of 5-Fluorouracil Pharmacokinetics in Cancer Patients with a C.1905+1G>A Mutation in DPYD by Means of a Bayesian Limited Sampling Strategy
- (2012) André B. P. van Kuilenburg et al. CLINICAL PHARMACOKINETICS
- Population Pharmacokinetic Analysis of 5-FU and 5-FDHU in Colorectal Cancer Patients: Search for Biomarkers Associated with Gastro-Intestinal Toxicity
- (2012) Christian Woloch et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Pharmacokinetics of orally administered uracil in healthy volunteers and in DPD-deficient patients, a possible tool for screening of DPD deficiency
- (2011) Maurice C. van Staveren et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Time-Dependent Pharmacokinetics of 5-Fluorouracil and Association With Treatment Tolerability in the Adjuvant Setting of Colorectal Cancer
- (2011) Toni Ibrahim et al. JOURNAL OF CLINICAL PHARMACOLOGY
- The current landscape of locally advanced rectal cancer
- (2011) Mebea Aklilu et al. Nature Reviews Clinical Oncology
- Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity
- (2011) Ursula Amstutz et al. PHARMACOGENOMICS
- DPD-based adaptive dosing of 5-FU in patients with head and neck cancer: impact on treatment efficacy and toxicity
- (2010) Chen Guang Yang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Routine Dihydropyrimidine Dehydrogenase Testing for Anticipating 5-Fluorouracil–Related Severe Toxicities: Hype or Hope?
- (2010) Joseph Ciccolini et al. Clinical Colorectal Cancer
- Pharmacogenetic tests in cancer chemotherapy: what physicians should know for clinical application
- (2010) Soo-Youn Lee et al. JOURNAL OF PATHOLOGY
- Pharmacokinetics, a main actor in a many-sided approach to severe 5-FU toxicity prediction
- (2008) Guido Bocci et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- 5-Fluorouracil Pharmacokinetics Predicts Disease-free Survival in Patients Administered Adjuvant Chemotherapy for Colorectal Cancer
- (2008) A. Di Paolo et al. CLINICAL CANCER RESEARCH
- Individual Fluorouracil Dose Adjustment Based on Pharmacokinetic Follow-Up Compared With Conventional Dosage: Results of a Multicenter Randomized Trial of Patients With Metastatic Colorectal Cancer
- (2008) Erick Gamelin et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started